Back to top

Analyst Blog

We are reiterating out Neutral recommendation on UnitedHealth Group Inc. (UNH - Analyst Report). Though bottom line fell short of the year-ago earnings, it was in line with the Zacks Consensus Estimate.

Why Reiterate?

Following the release of UnitedHealth’s first-quarter results, estimates have been revised downward. Net income of $1.16 per share was in line with the Zacks Consensus Estimate. Earnings, however, declined 11.4% on a year-over-year basis. UnitedHealth, for the second consecutive quarter, reported in line with our estimate.

The Zacks Consensus Estimate for 2012 moved down by 0.2% to $5.44 as 11 of 14 estimates moved south over the last 30 days. For 2013, 12 of 14 estimates moved down pulling the Zacks Consensus Estimate by 0.4% to $5.84 over the same time frame.

UnitedHealth expects to generate $122 billion in revenues in 2013, an increase of nearly 10% from 2012 level. Net earnings are still expected between $5.25 and $5.50 per share.

We are bullish about the company’s long-term growth prospects. It has strengthened its key capabilities to respond to the emerging growth opportunities. These initiatives have been taken to expand its Medicaid and Medicare business, grow the health service business and expand the international operations. Additionally, it has been successfully growing its membership. With the implementation of TRICARE Contract, it added 2.9 million military market beneficiaries.

The company also remains focused to return more value to its shareholders.

However, certain headwinds such as high unemployment, growing medical costs, and pressure from Health Care overhaul might weigh on its positives. Nevertheless, we believe the company will beat the odds given its diversified business model with leading market share positions in the Commercial, Medicare, and Medicaid markets.

UnitedHealth carries a Zacks Rank #3 (Hold).

Other Stocks to Consider

Apart from UnitedHealth, other stocks in the HMO industy that are currently performing well include Aetna Inc. (AET - Analyst Report), Health Net Inc. (HNT - Analyst Report) and Humana Inc. (HUM - Analyst Report). All these companies carry a Zacks #2 Rank (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UNITED THER… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%